Home > > > Report Detail

United States Generic Drugs Market, By Therapeutic Application (CNS, Cardiovascular, Dermatology, Oncology, GU, Respiratory, Anti-infective & Others], Companies

Publisher Name :
Date: 08-Jun-2018
No. of pages: 120
Inquire Before Buying

United States Generic Drugs Market is projected to exceed USD 210 Billion by 2024. United States Generic Drugs Market is so huge that nearly 80% of dispensing prescriptions accounts generic drugs. According to FDA in the United States 9 out of 10 prescriptions filled are for generic drugs. Most of the physicians and hospitals are now prescribing generic drugs than that of the brand-name drugs. Generic Drugs are those drugs which have same active component as patent drugs in same outline & equal amounts. Generic drugs are also called as Off-Label drugs.

The prime reason for the growth of United States Generic Drugs Market can be attributed to its pricing, on an average generic (Off-Label) drug is around 40-60% cheaper than those of Branded Drugs. However, this price of generic drug further declines, when various generic drug companies target a single approved drug, then market competition results in prices 85% less than the branded drugs. Also, increasing number of drug patent expirations, government initiatives and rising prevalence of chronic diseases are some other factoRenub Research report titled United States Generic Drugs Market, By Therapeutic Application [Central Nervous System (CNS), Cardiovascular, Dermatology, Genitourinary (GU)/Harmonal Drugs, Respiratory, Anti-infective, Oncology & Others], Companies (Teva, Mylan N.V., Sandoz, Endo Pharmaceuticals, Lupin Limited, Dr Reddy’s, Sun Pharma, & Others)” provides a complete analysis of US Generic Drugs Market. rs which are expected to propel the growth of United States Generic Drugs Market in the near future.

Therapeutic Application – Oncology Generic Drug Market is likely to witness a Significant Growth during the Forecast Period

The report studies the market of the following Therapeutic Application segments: Central Nervous System (CNS), Cardiovascular, Dermatology, Genitourinary (GU) / Harmonal Drugs, Respiratory, Anti-infective, Oncology & Others. Central Nervous System (CNS), Cardiovascular, Respiratory and Oncology are some of the segments that will attract the attention of generic drugs market participants.

All companies in this report has been covered with following view points


  • Company Strategy

  • Sales


Companies Analysis

Teva, Mylan, Sandoz, Endo Pharmaceuticals, Lupin Limited, Dr Reddy’s, Sun Pharma are some of the top companies operating in the United States Generic Drug Market; which has been studied thoroughly in the report

By Therapeutic Application:


  • Central Nervous System (CNS)

  • Cardiovascular

  • Dermatology

  • Genitourinary (GU)/Harmonal Drugs

  • Respiratory

  • Anti-infective

  • Oncology

  • Others


Key Companies Covered in the Report:


  • Teva

  • Mylan N.V.

  • Sandoz

  • Endo Pharmaceuticals

  • Lupin Limited

  • Dr Reddy’s

  • Sun Pharma

  • Others

United States Generic Drugs Market, By Therapeutic Application (CNS, Cardiovascular, Dermatology, Oncology, GU, Respiratory, Anti-infective & Others], Companies

Table of Contents

1. Executive Summary

2. United States Pharmaceutical Market
2.1 Branded Pharmaceutical Market
2.2 Generics Pharmaceutical Market

3. United States Generic Drugs Saving

4. Market Share – United States Pharmaceutical
4.1 Branded vs. Generics Drugs
4.2 Branded Generic vs. Unbranded Generic Drug
4.3 Volume Penetration – Generic vs. Branded Drugs
4.4 Therapeutic Application

5. United States Generic Drugs Market (2010 – 2024)
5.1 Branded Generic Drugs Market
5.2 Unbranded Generic Drugs Market

6. Therapeutic Application – United States Generic Drugs Market (2010 – 2024)
6.1 Central Nervous System (CNS)
6.2 Cardiovascular
6.3 Dermatology
6.4 Genitourinary / Hormonal Drugs
6.5 Respiratory
6.6 Anti-infective
6.7 Oncology
6.8 Others

7. Teva Pharmaceutical Industries Ltd - Company Analysis
7.1 Product Launch
7.1.1 Point No. 1
7.1.2 Point No. 2
7.1.3 Point No. 3
7.1.4 Point No. 4
7.1.5 Point No. 5
7.1.6 Point No. 6
7.2 Financial Insight

8. Mylan N.V. - Company Analysis
8.1 Product Launch
8.1.1 Point No. 1
8.1.2 Point No. 2
8.1.3 Point No. 3
8.1.4 Point No. 4
8.1.5 Point No. 5
8.1.6 Point No. 6
8.2 Financial Insight

9. Sandoz Inc. - Company Analysis
9.1 Product Launch
9.1.1 Point No. 1
9.1.2 Point No. 2
9.2 Financial Insight

10. Endo Pharmaceuticals - Company Analysis
10.1 Product Launch
10.1.1 Point No. 1
10.1.2 Point No. 2
10.1.3 Point No. 3
10.1.4 Point No. 4
10.2 Financial Insight

11. Lupin Limited - Company Analysis
11.1 Product Launch
11.1.1 Point No. 1
11.1.2 Point No. 2
11.1.3 Point No. 3
11.1.4 Point No. 4
11.1.5 Point No. 5
11.1.6 Point No. 6
11.1.7 Point No. 7
11.2 Financial Insight

12. Dr Reddy's - Company Analysis
12.1 Business Portfolio
12.1.1 Point No. 1
12.1.2 Point No. 2
12.1.3 Point No. 3
12.2 Financial Insight

13. Sun Pharmaceutical Industries Ltd. - Company Analysis
13.1 Product Launch
13.1.1 Point No. 1
13.1.2 Point No. 2
13.1.3 Point No. 3
13.1.4 Point No. 4
13.2 Financial Insight

14. Others
14.1 Financial Insight

15. Growth Driver
15.1 Rising Geriatric Population of United States
15.2 Generic Drugs Cost less than Brand Name Drugs
15.3 Rising Incidence of non-communicable Diseases

16. Challenges
16.1 Lack of Regulation & Information
16.2 Long Halt for Expiration of Patent Drug

List of Tables:

Table 3-1: Top 10 Generic Drugs Ranked by Savings in US - 2016
Table 3-2: Ten Major US State Generic Saving in - 2016
Table 6-1: The Full Burden of 24 Skin Disease categories

List of Figures:

Figure 2‑1: US Pharma Market (Billion US$), 2010 – 2017
Figure 2‑2: Forecast for US Pharma Market (Billion US$), 2018 – 2024
Figure 2‑3: US Branded Pharma Market (Billion US$), 2010 – 2017
Figure 2‑4: Forecast for US Branded Pharma Market (Billion US$), 2018 – 2024
Figure 2‑5: US Generics Pharma Market (Billion US$), 2010 – 2017
Figure 2‑6: Forecast for US Generics Pharma Market (Billion US$), 2018 – 2024
Figure 3‑1: Savings from Generics in (Billions US$), - 2016
Figure 3‑2: US Generic Saving (Billion US$), 2010 – 2017
Figure 3‑3: Forecast for US Generic Saving (Billion US$), 2018 – 2024
Figure 4‑1: US Pharmaceutical Market Share (%), 2010 – 2017
Figure 4‑2: Forecast for US Pharmaceutical Market Share (%), 2018 – 2024
Figure 4‑3: Generic Drug Market Share (%), 2010 – 2017
Figure 4‑4: Forecast for Generic Drug Market Share (%), 2018 – 2024
Figure 4‑5: US Generic V.S. Branded Drug Volume Penetration (%), 2010 – 2017
Figure 4‑6: Forecast for US Generic V.S. Branded Drug Volume Penetration (%), 2018 – 2024
Figure 4‑7: US Generic Drugs - By Therapeutic Application Market Share (%), 2010 - 2017
Figure 4‑8: Forecast for US Generic Drugs - By Therapeutic Application Market Share (%), 2018 - 2024
Figure 5‑1: Branded Generic Drug Market (Billion US$), 2010 – 2017
Figure 5‑2: Forecast for Branded Generic Drug Market (Billion US$), 2018 – 2024
Figure 5‑3: Unbranded Generic Drug Market (Billion US$), 2010 – 2017
Figure 5‑4: Forecast for Unbranded Generic Drug Market (Billion US$), 2018 – 2024
Figure 6‑1: Central Nervous System Market (Billion US$), 2010 – 2017
Figure 6‑2: Forecast for Central Nervous System Market (Billion US$), 2018 – 2024
Figure 6‑3: U.S Incidence of cardiovascular disease by age and sex -2013
Figure 6‑4: Cardiovascular Market (Billion US$), 2010 – 2017
Figure 6‑5: Forecast for Cardiovascular Market (Billion US$), 2018 – 2024
Figure 6‑6: Skin Diseases Prevalence in US – 2013
Figure 6‑7: Dermatology Market (Million US$), 2010 – 2017
Figure 6‑8: Forecast for Dermatology Market (Million US$), 2018 – 2024
Figure 6‑9: Genitourinary/Hormonal Drugs Market (Billion US$), 2010 – 2017
Figure 6‑10: Forecast for Genitourinary/Hormonal Drugs Market (Billion US$), 2018 – 2024
Figure 6‑11: Respiratory Market (Billion US$), 2010 – 2017
Figure 6‑12: Forecast for Respiratory Market (Billion US$), 2018 – 2024
Figure 6‑13: Anti-infective Market (Billion US$), 2010 – 2017
Figure 6‑14: Forecast for Anti-infective Market (Billion US$), 2018 – 2024
Figure 6‑15: Oncology Market (Billion US$), 2010 – 2017
Figure 6‑16: Forecast for Oncology Market (Billion US$), 2018 – 2024
Figure 6‑17: Others Market (Billion US$), 2010 – 2017
Figure 6‑18: Forecast for Others Market (Billion US$), 2018 – 2024
Figure 7‑1: Teva – US Generic Drugs Market (Million US$), 2011 – 2017
Figure 7‑2: Forecast for Teva – US Generic Drugs Market (Million US$), 2018 – 2024
Figure 8‑1: Mylan NV – US Generic Drugs Market (Million US$), 2011 – 2017
Figure 8‑2: Forecast for Mylan NV – US Generic Drugs Market (Million US$), 2018 – 2024
Figure 9‑1: Sandoz – US Generic Drugs Market (Million US$), 2011 – 2017
Figure 9‑2: Forecast for Sandoz – US Generic Drugs Market (Million US$), 2018 – 2024
Figure 10‑1: Endo Pharmaceuticals – US Generic Drugs Market (Million US$), 2012 – 2017
Figure 10‑2: Forecast for Endo Pharmaceuticals – US Generic Drugs Market (Million US$), 2018 – 2024
Figure 11‑1: Lupin Limited – US Generic Drugs Market (Million US$), 2011 – 2017
Figure 11‑2: Forecast for Lupin Limited – US Generic Drugs Market (Million US$), 2018 – 2024
Figure 12‑1: Dr Reddy’s – North America (US & Canada) Generic Drugs Market (Million US$), 2011 – 2017
Figure 12‑2: Forecast for Dr Reddy’s – North America (US & Canada) Generic Drugs Market (Million US$), 2018 – 2024
Figure 13‑1: Sun Pharma –US Generic Drugs Market (Million US$), 2011 – 2017
Figure 13‑2: Forecast for Sun Pharma –US Generic Drugs Market (Million US$), 2018 – 2024
Figure 14‑1: Others - US Generic Drugs Market (Million US$), 2011 – 2017
Figure 14‑2: Forecast for Others –US Generic Drugs Market (Million US$), 2018 – 2024
Figure 15‑1: United States - Rising Geriatric Population (Million), 2000, 2016 & 2060

  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs